We are live on
!
Find out more
FVCM
F&V Capital Management Portfolio holdings
AUM
$473M
1-Year Est. Return
35.42%
This Fund
S&P 500
This Quarter
Est. Return
+11.47%
1 Year Est. Return
+35.42%
3 Year Est. Return
+80.1%
5 Year Est. Return
+118.36%
10 Year Est. Return
+451.75%
AUM
$125M
AUM Growth
+$7.46M
(+6.3%)
Cap. Flow
-$4.64M
Cap. Flow
% of AUM
-3.7%
Top 10 Holdings %
Top 10 Hldgs %
37.72%
Holding
69
New
4
Increased
25
Reduced
26
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Expedia Group
EXPE
|
+$2.2M |
| 2 |
Hartford Financial Services
HIG
|
+$1.79M |
| 3 |
TQNT
TRIQUINT SEMICONDUCTOR INC
TQNT
|
+$1.63M |
| 4 |
CELG
Celgene Corp
CELG
|
+$1.14M |
| 5 |
WisdomTree US Total Dividend Fund
DTD
|
+$284K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tapestry
TPR
|
+$2.68M |
| 2 |
YHOO
Yahoo Inc
YHOO
|
+$2.62M |
| 3 |
FedEx
FDX
|
+$1.78M |
| 4 |
HES
Hess
HES
|
+$1.41M |
| 5 |
Morgan Stanley
MS
|
+$1.04M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.35% |
| 2 | Consumer Discretionary | 14.39% |
| 3 | Energy | 12.92% |
| 4 | Technology | 12.23% |
| 5 | Financials | 11.76% |
Similar funds
PCM
HW
CFC
DWM
CCM
KC
RCP
CTWM
F&V Capital Management's Q4 2013 Portfolio in Review
As of Q4 2013, F&V Capital Management held 69 positions worth $125M, up 6.3% from $118M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
F&V Capital Management withdrew a net $4.64M in Q4 2013, closing 9 positions and reducing 26 holdings. Its most notable exit was Teva Pharmaceuticals, an estimated $509K position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Energy.
Against the trend, F&V Capital Management opened a new position in Expedia Group worth $2.6M.
- F&V Capital Management's largest Q4 2013 buy was Expedia Group: 37,325 shares worth $2.6M.
- F&V Capital Management added most to Celgene Corp in Q4 2013, an estimated $1.14M increase.
- F&V Capital Management's biggest Q4 2013 reduction was Tapestry, cutting an estimated $2.68M.
- F&V Capital Management fully exited Teva Pharmaceuticals in Q4 2013, selling an estimated $509K.
- F&V Capital Management's ten largest holdings make up 38% of its $125M portfolio in Q4 2013.
- F&V Capital Management opened 4 new positions and closed 9 in Q4 2013.
- F&V Capital Management's portfolio value rose 6.3% quarter-over-quarter to $125M.
Based on F&V Capital Management's 13F filing for Q4 2013, filed 5 Feb 2014.